2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on mCRC: Can 3L T-DXd Be Effective in HER2+ Disease?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Richard Kim
By 2020 ASCO Virtual Direct™ Highlights FEATURING Richard Kim
306 views
August 20, 2020
Comments 1
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn
GI
07:16

2020 ASCO Updated BEACON Results on BRAF V600E mCRC: Is the FDA Appr…

2020 ASCO Virtual Direct™ Highlights

R. Kim

329 views
05:38

2020 ASCO Update on Pembro vs. Chemo in 1L dMMR / MSI-H mCRC: Did Re…

2020 ASCO Virtual Direct™ Highlights

R. Kim

404 views
07:21

2020 ASCO Update on mCRC: Can 3L T-DXd Be Effective in HER2+ Disease?

2020 ASCO Virtual Direct™ Highlights

R. Kim

306 views
05:15

2020 ASCO Update on Stage III Rectal Cancer: Neoadjuvant Short-Cours…

2020 ASCO Virtual Direct™ Highlights

R. Kim

923 views
06:14

2020 ASCO Update on Rectal Adenocarcinoma: Can Patients With a cCR t…

2020 ASCO Virtual Direct™ Highlights

R. Kim

1.2K views